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Age-period-cohort modelling of non-Hodgkin’s
lymphoma incidence in a French region: a period







Background: The incidence of non-Hodgkin’s lymphoma (NHL) has risen steadily during the last few decades in all
geographic regions covered by cancer registration for reasons that remain unknown. The aims of this study were
to assess the relative contributions of age, period and cohort effects to NHL incidence patterns and therefore to
provide clues to explain the increasing incidence.
Methods: Population and NHL incidence data were provided for the Doubs region (France) during the 1980-2005
period. NHL counts and person-years were tabulated into one-year classes by age (from 20 to 89) and calendar
time period. Age-period-cohort models with parametric smooth functions (natural splines) were fitted to the data
by assuming a Poisson distribution for the observed number of NHL cases.
Results: The age-standardised incidence rate increased from 4.7 in 1980 to 11.9 per 100,000 person-years at risk in
1992 (corresponding to a 2.5-fold increase) and stabilised afterwards (11.1 per 100,000 in 2005). Age effects showed
a steadily increasing slope up to the age of 80 and levelled off for older ages. Large period curvature effects, both
adjusted for cohort effects and non-adjusted (p < 10
-4 and p < 10
-5, respectively), showed departure from linear
periodic trends; period effects jumped markedly in 1983 and stabilised in 1992 after a 2.4-fold increase (compared
to the 1980 period). In both the age-period-cohort model and the age-cohort model, cohort curvature effects were
not statistically significant (p = 0.46 and p = 0.08, respectively).
Conclusions: The increased NHL incidence in the Doubs region is mostly dependent on factors associated with
age and calendar periods instead of cohorts. We found evidence for a levelling off in both incidence rates and
period effects beginning in 1992. It is unlikely that the changes in classification (which occurred after 1995) and the
improvements of diagnostic accuracy could largely account for the 1983-1992 period-effect increase, giving way to
an increased exposure to widely distributed risk factors including persistent organic pollutants and pesticides.
Continued NHL incidence and careful analysis of period effects are of utmost importance to elucidate the
enigmatic epidemiology of NHL.
Background
The aetiology of the most common forms of non-Hodg-
kin’s lymphoma (NHL) remains elusive [1]. The inci-
dence of NHL, however, has risen steadily in many
countries during the second half of the 20th century,
making this group of malignancies an increasingly
important contributor to the overall cancer burden. This
upward trend was observed in all geographic regions
covered by cancer registration and was not restricted to
any particular age group or gender or to predominantly
rural or urban areas [2]. This epidemic of NHL has now
begun to level off in North America and Europe [3],
with a recent downturn among white males aged 25-54
years in the USA [4] and among males aged 30-39 years
in the Nordic countries [5]. In France, incidence trends
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2005 (age-standardised incidence rates: 6.2 to 12.1 and
4.0 to 8.2 for males and females, respectively), with a
slower rate of increase from 2000 onwards [6]. The
interpretation of long-term trends in the incidence of
NHL has attracted much speculation in the absence of a
clear understanding of the risk factors. The generalised
increases in NHL incidence do not appear to be explic-
able only in terms of better diagnostics or classification
[7]. Moreover, it is now clear that AIDS-related NHL
accounts for a limited proportion of this increase in
developed countries [8]. Thus, most authors agree that
the steady increases in NHL rates up to the late 1990s
almost certainly reflect real increases in disease inci-
dence [9].
The escalation in NHL incidence suggests increasing
exposure to one or more ubiquitous lymphomagenic
agents [1] and could therefore be partly explained by
environmental exposure to common chemicals (such as
persistent organic pollutants or pesticides). One dioxin
congener (2,3,7,8-T4CDD or TCDD) and one furan con-
gener (2,3,4,7,8-P5CDF) are considered carcinogenic to
humans by the International Agency for Research on
Cancer for all cancers combined [10]. For NHL specifi-
cally, increased incidence and mortality have been
reported in several investigations conducted on cohorts
of workers exposed to TCCD [11-14], on the population
exposed to the accidental industrial release in Seveso
(Italy) [15] and among neighbours of municipal solid
waste incinerators [16,17]. Polychlorinated biphenyl
(PCB) 126 is also classified as a known human carcino-
gen [10] and there is mounting evidence of a relation-
ship between PCBs and NHL risk [18-21]. Recent
reviews have highlighted pesticide exposure as one of
the likely occupational risk factors for NHL [22,23].
Further elucidation of the temporal changes in NHL
incidence has important epidemiologic and public health
implications [4]. In this context, it is important to
understand whether these time trends are related to age,
calendar period or birth cohort because these time
scales are surrogates or proxy measures for other influ-
ences. Although age-period-cohort (APC) models are
descriptive tools, the identification of changes in the
magnitude of long-term trends can have important
aetiological implications [24]. They are therefore likely
to further our knowledge of the enigmatic aetiology of
NHL [2,25]. More precisely, if the environmental
hypothesis holds, it should result in increased period
effects (indicative of changes in risk factors that affect
all ages equally). Additionally, prenatal exposure to
environmental risk factors during a given time period
would induce a birth cohort effect.
Cancer registration does not cover the whole French
population. In 1992, the situation was particularly
unfavourable, as cancer registration covered only 3% of
the population and this included specialized cancer
registries that collect data on certain types of cancer
only [26]. Established in 1976, the Doubs Cancer Regis-
try is the second oldest cancer registry in France. This
long tenure provides a uniq u eo p p o r t u n i t yt oe x p l o r e
temporal changes in French cancer incidence.
The aims of this study were to assess the relative con-
tributions of age, period and cohort effects to NHL inci-
dence patterns and therefore to provide clues to explain
the increasing incidence in the French Doubs region.
Methods
Study site
The Doubs region (5233 km
2, 499 162 inhabitants in
1999) is located in eastern France along the Swiss bor-
der. Mainly rural, this region is, however, industrialized
in its north-eastern part.
Population data
Population data were available from the French Census
Bureau from 1980 to 2005. The person-years of observa-
tion were tabulated into one-year classes by age (from 0 to
99+) and calendar time period (from 1980 to 2005) [6,27].
Cancer cases
Although the Doubs Cancer Registry was established in
1976, only NHL incidence data registered between 1980
and 2005 were included to minimise the risk of under-
registration in the early years. With only one tertiary
referral hospital in the region (the University Hospital),
reporting is homogeneous and complete, as ascertained
by the ratio of the number of deaths to the number of
cases registered during 1983-1987, which at 47% is very
similar to those reported in other Western countries
[28]. Virtually all cases were histologically verified (99%).
The International Classification of Disease for Oncology,
third edition (ICD-O-3), has been used to classify cases
since the 2002 diagnosis year, but for cases diagnosed
before 2002 and classified according to earlier versions
of ICD O, the IARCtools program was used to convert
codes to ICD-O-3 [29]. When required by the software,
a hand review was performed by a medical expert in
cancer registration for complete conversion. The Doubs
cancer registry extracted anonymous NHL cases (using
the ICD-O-3 morphology codes M9590-9596/3, M9670-
9719/3, M9727-9729/3 and 9832-9834/3) and tabulated
them into one-year classes by age and calendar time
period. The lack of an adequate sample size precluded
analyses by histological subtype. The procedures at the
Doubs cancer registry were approved by the French
National Cancer Registry Committee and the National
Commission for the Confidentiality of Computerized
Data.
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Age-standardised rates were calculated with the World
Health Organization (WHO) world population serving
as the standard [30].
We restricted the APC analysis to cases aged 20-89
because of too few events in the younger age groups and
lower data quality in the oldest age group. To obtain the
effects of age, period and cohort, a log-linear model was
fitted to the data by assuming a Poisson distribution for
the observed number of NHL cases. The general form of
the multiplicative APC model for rates, l( a ,p )a ta g eai n
period p for persons in cohort c = p - a, is as follows:
log[ ( , )] ( ) ( ) ( ),  ap fa gp hc =++
where a, p and c represent the mean age, period and
cohort, respectively, for the observational units; f, g and
h are parametric functions.
The “classical” approach to modelling APC effects, in
which variables are defined as “factors”,u s e so n ep a r a -
meter per distinct value of age, period and cohort to
accommodate the non-linearity of the effects. Because
the three variables of age, period and cohort were origin-
ally continuous, we modelled these effects by parametric
smooth functions. Restricted B-splines (natural splines)
with seven parameters for the age, period and cohort
terms were incorporated in the APC model to reduce
random variation. We arranged the relevant submodels
into a sequence that gives all the relevant comparisons
between adjacent lines from an analysis of deviance. To
test for the significance of effects between nested models,
we compared the difference in deviance between these
different models using the F test. Statistical significance
was attributed to two-sided p-values < 0.05.
To allow reconstruction of the fitted rates from the
reported values and to overcome the so-called identifia-
bility problem, we chose the following parameterisation
proposed by Carstensen [31]. We had an a priori
assumption that mainly period-effects drive the change
in rates, considering that the whole population would be
equally exposed to environmental risk factors and sup-
ported by the fact that risk factors for NHL seem to be
unrelated to birth cohort [32]. We therefore fitted mod-
els sequentially. First, we fit an age-period model, choos-
ing the first year (1980) as the reference period. Second,
the logarithms of the fitted values from this model were
used as an offset variable in a model with cohort effects.
Third, the cohort effects from this model were used as
the residual log rate ratios by cohort. The drift para-
meter (representing a linear secular trend not exclu-
sively identifiable as a period or cohort effect) was
extracted using the weighted average (by marginal num-
ber of cases). The age function is interpretable as the
log of the age-specific rates for the reference period (i.e.,
cross-sectional rates). The period function represents
the log-rate ratios relative to the reference period, while
the cohort function represents the log-rate ratios relative
to the age-period prediction (residual log-rate ratios). In
examining these functions, minor fluctuations should
not lead to direct, thus limited, interpretation; only the
major overall trends should be considered.
A l ld a t aw e r ea n a l y s e du s i n gt h eR2 . 1 0 . 0s t a t i s t i c a l




A total of 1,457 incident cases of NHL were registered
in the Doubs region between 1980 and 2005 in the age
group from 20-89 years, for a corresponding population
of 367,842 in 1999 (census data).
The age-standardised incidence rate increased from
4.7 in 1980 to 11.9 per 100,000 person-years at risk in
1992 (corresponding to a 2.5-fold increase) and stabi-
lised afterwards (11.1 per 100,000 in 2005). The
observed rates, aggregated into 5-year periods and 10-
year age classes to produce fairly stable rates, are plotted
in Figure 1. A clear gradient of higher NHL incidence
rates with increasing age is observed throughout the
analysed period. No interaction between age and period
is noticeable, as indicated by the parallel lines (on a log
scale) in the first and third plots. Age-specific rates are
therefore proportional between periods, suggesting an
age-period model. There is a clear tendency in the
1980-1984 period that shows lower rates than subse-
quent periods. No clear pattern emerges from the
cohort curves.
Age-period-cohort analysis
T h ed a t as u p p o r t e dad e v e l o p m e n to fN H Li n c i d e n c e
more complex than a mere linear trend over time. Table
1 shows the changes in deviance in the sequential build-
ing of the model. The age-drift model significantly
i m p r o v e dt h ef i to v e rt h ea g e - o n l ym o d e l( p<1 0
-15).
Large period curvature effects, both adjusted for cohort
effects and non-adjusted (p < 10
-4 a n dp<1 0
-5, respec-
tively), showed departure from linear periodic trends. In
both the APC model and the AC model, cohort curva-
ture effects were not statistically significant (p = 0.46
and p = 0.08, respectively).
The age, period and cohort effects are displayed in
Figure 2 on a directly comparable scale, allowing the
slopes of the effects to be compared. Age effects showed
a steadily increasing slope up to the age of 80, levelling
off for older ages. From the period-effect curve, two non
linear and thus identifiable changes merit special atten-
tion: period effects jumped markedly in 1983 and stabi-
lised in 1992 after a 2.4-fold increase (compared to the
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conditional cohort rate ratios remained close to one and
did not vary significantly (all rate ratio 95% confidence
intervals included one, while broadening at the extremes
due to low NHL counts).
Discussion
The detailed tabulation combined with parametric
smooth functions allowed relevant features to be cap-
tured. The striking observation from this APC analysis
concerns the strong 1983-1992 period effect highlighted
in the Doubs region. These two inflection points are
second-order features and are therefore not an artefact
of the parameterisation.
We took advantage of the long tenure of the Doubs
registry database to analyse trends in the incidence of
NHL over a sufficiently extended time period (26 years).
NHL comprises many histologically distinct lymphocyte
malignancies, each with putatively distinct aetiologies
(and time scale patterns). Unfortunately, in this study,
the NHL subtypes were not considered because small
case counts precluded the detection of subtle changes in
APC effects.
In the Doubs region, age-standardised NHL incidence
rates and trends are similar to those reported from
other European countries [3,33]. Although changes in
the NHL incidence are discussed at length in the medi-
cal literature, few studies have attempted to separate the
respective contributions of the three time-scales to the
observed trends. Using the Clayton-Schiffers method,
McNally et al. found no evidence of non-linear period
or non-linear cohort effects during the period from
Figure 1 Incidence of non-Hodgkin’s lymphoma per 100,000 person-years by age and birth cohort (age group 20-89 years, 1980-
2005, Doubs region, France). Top left: Age on the x-axis; the rates corresponding to the same period are connected by lines. Top right: Age
on the x-axis; the rates corresponding to the same cohorts are connected by lines. Bottom left: Period on the x-axis; the rates corresponding to
the same age groups are connected by lines. Bottom right: Cohort on the x-axis; the rates corresponding to the same age groups are connected
by lines.
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out APC analyses but replaced the period of diagnosis
with a variable reflecting the availability of new medical
technologies (to avoid the identifiability problem), which
is a questionable assumption [9]. They ascribed the
increase in incidence (Spain, 1973-1991) to period and
cohort effects. Bray et al. used Bayesian APC models
(mainly to project NHL incident rates) and concluded
there was a mixture of period and cohort effects (with-
out further specification) in nine different countries
(1973-1992) [2]. Liu et al. concluded that period effects
played a major role in NHL incidence trends between
1970 and 1996 in Canada [34]. Sandin et al. stressed the
predominance of calendar period over birth cohort
effects in the Nordic countries from 1960 through 2003
[5]. Adamson et al. modelled only the drift [32].
The overall time trend patterns of our study fit with
the APC-specific assessments by Sandin et al. and Liu et
al. [5,35]. In terms of the interpretation of period effects,
three factors may have affected the observed trends:
multiple schemes for lymphoma classification, advance-
ments in diagnosis and widely distributed risk factors.
The complex and evolving classification may have had
some role particularly between 1995 and 2001. During
this period, diagnoses were originally described by
pathologists using the WHO classification (an extension
of the former Revised European American classification
of Lymphoid Neoplasms [REAL]), but diagnoses were
coded by cancer registries as ICD-O-2 (incorporating
another scheme, the Working Formulation) [33]. Con-
versely, ICD-O-3, used by cancer registries to classify
cases from 2002 onwards, is known to reduce misclassi-
fication bias [36,37]. Consider i n gt h et i m el a gb e t w e e n
the increase in period effects (1983-1992) and the evol-
ving classification (from 1995 onwards), it is unlikely
that the latter could explain the former.
An increase in period effects may also relate to the com-
bined effects of improvements in NHL detection (lowering
the threshold of detection) and the widespread use of new
methods and techniques (allowing greater access to inter-
ventions) [35]. In this scenario, NHL incidence rates
would be maintained at their current level (due to the full
Table 1 Comparison of age-period-cohort submodels for
the incidence of non-Hodgkin’s lymphoma to separate
contributions from each of the time variables (age group
20-89 years, 1980-2005, Doubs region, France)
Terms in model D
a (df) Effect ΔD( Δdf) p value
Age 1848 (1812) - - -
Age + Drift 1764 (1811) δ
b|A 84 (1) < 10
-15
Age + Period 1727 (1805) P
c|A 37 (6) < 10
-5
Age + Period + Cohort 1721 (1799) C
c|A, P 6 (6) 0.46
Age + Cohort 1753 (1805) P
c|A, C 32 (6) < 10
-4
Age + Drift 1764 (1811) C
c|A 11 (6) 0.08
a deviance
b drift or linear secular trend
c curvature or non-linear effect
d the submodels are arranged in a sequence that gives all the relevant tests
as comparisons between adjacent lines (using the difference in deviances and
the F test). The successive tests (all adjusted for age) refer therefore to the
drift, the non linear effect of period, the non linear effect of cohort (adjusted
for period), the non linear effect of period (adjusted for cohort) and the non
linear effect of cohort.
Figure 2 Estimated effects from the age-period-cohort model (non-Hodgkin’s lymphoma, age group 20-89 years, 1980-2005, Doubs
region, France). The centermost curve represents the age-specific rates for 100,000 person-years at risk during the reference period (1980). The
median curve shows the rate ratios of cohorts conditional on the estimated age and period effects. The rightmost curve shows the rate ratios of
periods relative to the reference period (1980). Fitted values are plotted together with 95% confidence limits.
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ing the totality of disease in a population.
The changes in classification and the improvements of
diagnostic accuracy cannot largely account for the steady
increases registered in NHL incidence rates up to the late
1990s [3,7], giving way to an increasing exposure to risk
factors as the more likely explanation. Because everyone
broadly consumes the same food items and shares essen-
tially the same outdoor environment, toxicants present in
the food chain or in the environment could influence dis-
ease incidence. However, the contribution of other
potential risk factors (diet rich in proteins and fats, or
medical drugs) cannot be ruled out [35].
The 1983-1992 period-effect increase highlighted in the
present study, affecting all ages equally, could be due to
one or more exposures that emerged during the 1960s
(considering a 20-year latency period), with a wide and
increasing use and release into the environment. Agents
with immunosuppressive activity, such as persistent
organic pollutants (dioxins, chlorophenols and polychlori-
nated biphenyls) and pesticides (particularly the phenoxya-
cetic acids) meet these criteria [38,39]. Although exposure
to pesticides has mainly been occupational, the situation
for persistent organic pollutants is quite different because
the whole population was exposed, mainly thorough the
food chain (e.g., fatty fish, meat, dairy products). In this
respect, the majority of exposure would not come from
the Doubs region because most of these food products
were not produced locally but rather had been transported
over hundreds of kilometres. These suspected widely dis-
tributed risk factor first increased and subsequently
decreased (because of regulations enforced in France in
the 1980s and the 1990s). Thus, if the environmental
hypothesis holds, the period effects of NHL incidence (and
not only the incidence rates) are expected to start their
decline in the near future.
Conclusions
The increased NHL incidence in the Doubs region is
mostly dependent on factors associated with age and
calendar periods instead of cohorts. We found evidence
for a levelling off in both incidence rates and period
effects beginning in 1992. Continued NHL incidence
surveillance and careful analysis of period effects are of
utmost importance to elucidate the enigmatic epide-
miology of NHL.
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